- Home
- Publications
- Publication Search
- Publication Details
Title
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-28
DOI
10.3389/fmed.2022.916693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors
- (2022) Tran T. Hoang et al. MOLECULAR IMAGING AND BIOLOGY
- Pilot study of the diagnostic utility of 89 Zr‐df‐IAB2M and 68 Ga‐PSMA‐11 PET imaging and multiparametric MRI in localized prostate cancer
- (2022) Panagiotis J. Vlachostergios et al. PROSTATE
- Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET
- (2022) Kyung-Ho Jung et al. Molecular Imaging
- Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers
- (2021) Qingzhu Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma
- (2021) Miao Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma
- (2021) Robin I. J. Merkx et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
- (2021) Reyhaneh Manafi-Farid et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma
- (2021) Natasha D. Sheybani et al. JOURNAL OF CONTROLLED RELEASE
- Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
- (2021) caroline bodet-milin et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells
- (2021) Jin Won Park et al. Scientific Reports
- Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography
- (2021) Ruth González-Gómez et al. Journal of Clinical Medicine
- Targeted PET/CT imaging for clear cell renal cell carcinoma with radiolabeled antibodies: recent developments using girentuximab
- (2021) Tim van Oostenbrugge et al. CURRENT OPINION IN UROLOGY
- The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers
- (2021) Virginia Liberini et al. MOLECULES
- Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo
- (2021) Emanuel Peplau et al. Scientific Reports
- Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition
- (2021) Oladapo O. Yeku et al. Frontiers in Immunology
- Immuno-PET Molecular Imaging of RANKL in Cancer
- (2021) Jonatan Dewulf et al. Cancers
- Whole-body PET imaging of T cell response to Glioblastoma
- (2021) Tomomi W. Nobashi et al. CLINICAL CANCER RESEARCH
- ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
- (2021) Weiyu Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4+ T Cells
- (2021) Ashraful Islam et al. JOURNAL OF IMMUNOLOGY
- First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer
- (2021) Anna-Larissa Nadia Niemeijer et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers
- (2021) Zhaoguo Han et al. MOLECULAR IMAGING AND BIOLOGY
- Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model
- (2021) Aditya Bansal et al. NUCLEAR MEDICINE AND BIOLOGY
- Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma
- (2021) Alexandra Foster et al. EBioMedicine
- A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts
- (2021) Arutselvan Natarajan et al. Cancers
- Next-Generation Molecular Imaging of Thyroid Cancer
- (2021) Yuchen Jin et al. Cancers
- PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
- (2021) Mohamed El Fakiri et al. Cancers
- 89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
- (2021) I.C. Kok et al. ANNALS OF ONCOLOGY
- ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
- (2021) Sai Kiran Sharma et al. CLINICAL CANCER RESEARCH
- Pilot-phase PET/CT study targeting integrin αvβ6 in pancreatic cancer patients using the cystine-knot peptide–based 18F-FP-R01-MG-F2
- (2021) Ryusuke Nakamoto et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic value of 2-[18F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy
- (2021) Gregor Schweighofer-Zwink et al. EUROPEAN JOURNAL OF RADIOLOGY
- Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model
- (2021) Benjamin B. Kasten et al. Scientific Reports
- Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
- (2021) Reyhaneh Manafi-Farid et al. Cancers
- Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography
- (2021) Eduardo Ruiz-López et al. Cancers
- Construction of 124I-trastuzumab for noninvasive PET imaging of HER2 expression: from patient-derived xenograft models to gastric cancer patients
- (2020) Xiaoyi Guo et al. Gastric Cancer
- Clinical Translation of a 68Ga-labeled Integrin αvβ6-targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer
- (2020) Xun Feng et al. JOURNAL OF NUCLEAR MEDICINE
- Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging
- (2020) Lotte K. Kristensen et al. MOLECULAR IMAGING AND BIOLOGY
- Detecting TRA-1–60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent
- (2020) Jordan M. White et al. MOLECULAR PHARMACEUTICS
- ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
- (2020) Zunyu Xiao et al. CANCER RESEARCH
- ImmunoPET: Concept, Design, and Applications
- (2020) Weijun Wei et al. CHEMICAL REVIEWS
- Development and characterization of CD54-targeted immunoPET imaging in solid tumors
- (2020) Weijun Wei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer
- (2020) Caroline ROUSSEAU et al. JOURNAL OF NUCLEAR MEDICINE
- Small molecules, big impact: 20 years of targeted therapy in oncology
- (2020) Philippe L Bedard et al. LANCET
- An antibody drug conjugate targeting MUC1 associated carbohydrate CA6, shows promising anti-tumor activities
- (2020) Celine Nicolazzi et al. MOLECULAR CANCER THERAPEUTICS
- Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [18F]AlF-Affibody Conjugates
- (2020) Chiara Da Pieve et al. MOLECULES
- 89Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe
- (2020) Kimberly Fung et al. MOLECULES
- 64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time
- (2020) Kentaro Fujiwara et al. NUCLEAR MEDICINE COMMUNICATIONS
- Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive In Vivo Imaging of Thyroid Cancer
- (2020) Emanuel Peplau et al. THYROID
- Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer
- (2020) Yukie Yoshii et al. Scientific Reports
- Principles of Immunotherapy in Non-Small Cell Lung Cancer
- (2020) Melinda L. Hsu et al. Thoracic Surgery Clinics
- Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
- (2020) Weijun Wei et al. Advanced Science
- In vivo Imaging Technologies to Monitor the Immune System
- (2020) Claire E. McCarthy et al. Frontiers in Immunology
- Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate
- (2020) Stijn JH Waaijer et al. Journal for ImmunoTherapy of Cancer
- PET Imaging of VEGFR with a Novel 64Cu-Labeled Peptide
- (2020) Kuan Hu et al. ACS Omega
- Concurrent Injection of Unlabeled Antibodies Allows Positron Emission Tomography Imaging of Programmed Cell Death Ligand 1 Expression in an Orthotopic Pancreatic Tumor Model
- (2020) Jun Zhao et al. ACS Omega
- The role of fibroblast activation protein in health and malignancy
- (2020) Allison A. Fitzgerald et al. CANCER AND METASTASIS REVIEWS
- Targeted molecular imaging of head and neck squamous cell carcinoma: a window into precision medicine
- (2020) Jun Wu et al. CHINESE MEDICAL JOURNAL
- 2-[18F]FDG PET/CT radiomics in lung cancer: An overview of the technical aspect and its emerging role in management of the disease
- (2020) Reyhaneh Manafi-Farid et al. METHODS
- Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography
- (2020) Darpan N. Pandya et al. MOLECULES
- Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
- (2020) Brandon Nemieboka et al. NUCLEAR MEDICINE AND BIOLOGY
- Synthesis of a novel 89Zr-labeled HER2 affibody and its application study in tumor PET imaging
- (2020) Yuping Xu et al. EJNMMI Research
- Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study
- (2020) Y. Touchefeu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron Emission Tomography Imaging of Functional TGFβ Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors
- (2020) Alba Gonzalez-Junca et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- ImmunoPET Imaging of Pancreatic Tumors with 89Zr-Labeled Gold Nanoparticle–Antibody Conjugates
- (2020) Nicholas B. Sobol et al. MOLECULAR IMAGING AND BIOLOGY
- Antibody-Targeted Imaging of Gastric Cancer
- (2020) Komal Mandleywala et al. MOLECULES
- 89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs
- (2020) Elly L van der Veen et al. Journal for ImmunoTherapy of Cancer
- Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma
- (2020) Puey-Ling Chia et al. Pharmaceuticals
- Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using 89Zr-cetuximab
- (2020) Vu Long Tran et al. JOURNAL OF CONTROLLED RELEASE
- The Expression Profile and Textural Characteristics of C595-Reactive MUC1 in Pancreatic Ductal Adenocarcinoma for Targeted Radionuclide Therapy
- (2020) Ashleigh Hull et al. Cancers
- Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases
- (2020) Baptiste Pichon et al. Biomedicines
- PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules
- (2019) Shibo Qi et al. MOLECULAR IMAGING AND BIOLOGY
- CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma
- (2019) Weijun Wei et al. Advanced Science
- A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo
- (2019) Yu Tang et al. NUCLEAR MEDICINE AND BIOLOGY
- ImmunoPET imaging to assess target engagement: Experience from 89Zr-anti-HER3 mAb (GSK2849330) in patients with solid tumors
- (2019) Catharina Willemien Menke-van der Houven van Oordt et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
- (2019) Kirsten L. Moek et al. CLINICAL CANCER RESEARCH
- 89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma
- (2019) Raquel Benedetto et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Nanobody: outstanding features for diagnostic and therapeutic applications
- (2019) J.-Pablo Salvador et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Noninvasive Imaging and Quantification of Radiotherapy-Induced PD-L1 Upregulation with 89Zr–Df–Atezolizumab
- (2019) Emily B. Ehlerding et al. BIOCONJUGATE CHEMISTRY
- Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule
- (2019) Huawei Cai et al. MOLECULAR PHARMACEUTICS
- Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix
- (2019) Noor Jailkhani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
- (2019) Sarah R. Verhoeff et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle
- (2019) B. Frigerio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
- (2019) Patricia MR Pereira et al. JOURNAL OF NUCLEAR MEDICINE
- [89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model
- (2019) Kirstin A. Zettlitz et al. MOLECULAR IMAGING AND BIOLOGY
- A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer
- (2019) Alison Crawford et al. Science Translational Medicine
- Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
- (2019) Narittee Sukswai et al. Current Hematologic Malignancy Reports
- PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response
- (2019) Joseph Vento et al. Journal for ImmunoTherapy of Cancer
- Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis
- (2019) Hua Zhu et al. ACTA PHARMACOLOGICA SINICA
- CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic target
- (2019) Ayobami Matthew Olajuyin et al. Cancer Cell International
- Retooling a Blood-based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
- (2019) Christian Lohrmann et al. CLINICAL CANCER RESEARCH
- Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody
- (2019) Shubhanchi Nigam et al. MOLECULAR IMAGING AND BIOLOGY
- Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
- (2019) Mohammad Rashidian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
- (2019) Ren-Cai Lu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- 111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis
- (2019) Kentaro Fujiwara et al. ANNALS OF NUCLEAR MEDICINE
- Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer
- (2019) Aiko Yamaguchi et al. BMC CANCER
- Exploitation of CD133 for the targeted imaging of lethal prostate cancer
- (2019) Paige M Glumac et al. CLINICAL CANCER RESEARCH
- [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
- (2019) E. J. van Helden et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- First-in-human imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting
- (2019) Neeta Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model
- (2019) Jinquan Jiang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
- (2019) Camilla Christensen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts
- (2019) Hyungjun Cho et al. NUCLEAR MEDICINE AND BIOLOGY
- In vitro evaluation of the monoclonal antibody 64 Cu-IgG M75 against human carbonic anhydrase IX and its in vivo imaging
- (2018) Adam Čepa et al. APPLIED RADIATION AND ISOTOPES
- Pretargeted Immuno-PET Based on Bioorthogonal Chemistry for Imaging EGFR Positive Colorectal Cancer
- (2018) Xudong Shi et al. BIOCONJUGATE CHEMISTRY
- CD8+ T-cell density imaging with 64Cu-labeled cys-diabody informs immunotherapy protocols
- (2018) Jai Woong Seo et al. CLINICAL CANCER RESEARCH
- Positron Emission Tomography/Computed Tomography with 89 Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion
- (2018) Marlène C.H. Hekman et al. EUROPEAN UROLOGY
- Integrin αvβ6: Structure, function and role in health and disease
- (2018) Leeni Koivisto et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
- (2018) Masahide Matsuda et al. JOURNAL OF NEURO-ONCOLOGY
- Dual-modality immunoPET and near-infrared fluorescence (NIRF) imaging of pancreatic cancer using an anti-prostate cancer stem cell antigen (PSCA) cys-diabody
- (2018) Kirstin A Zettlitz et al. JOURNAL OF NUCLEAR MEDICINE
- Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
- (2018) Mark M Souweidane et al. LANCET ONCOLOGY
- Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model
- (2018) Freddy E. Escorcia et al. MOLECULAR IMAGING AND BIOLOGY
- Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models
- (2018) Lei Kang et al. MOLECULAR PHARMACEUTICS
- Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates
- (2018) Ali Azhdarinia et al. MOLECULAR PHARMACEUTICS
- Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET
- (2018) Michael Wagner et al. NUCLEAR MEDICINE AND BIOLOGY
- Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer
- (2018) Willemieke S. Tummers et al. PANCREAS
- Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
- (2018) Denis R. Beckford Vera et al. PLoS One
- RAGE-specific single chain Fv for PET imaging of pancreatic cancer
- (2018) Hye-Yeong Kim et al. PLoS One
- Anti–CTLA-4 therapy requires an Fc domain for efficacy
- (2018) Jessica R. Ingram et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
- (2018) Michiko Imamura et al. World Journal of Surgical Oncology
- 89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding
- (2018) Emilie M.J. van Brummelen et al. Oncotarget
- Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT
- (2018) Foubert Fanny et al. Oncotarget
- Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression
- (2018) Arutselvan Natarajan et al. Scientific Reports
- Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy
- (2018) Katrijn Broos et al. Theranostics
- Recent Development of Nuclear Molecular Imaging in Thyroid Cancer
- (2018) Huiting Liu et al. Biomed Research International
- Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
- (2018) Hui-Jun Zhao et al. Translational Cancer Research
- Targeting HER2 in Nuclear Medicine for Imaging and Therapy
- (2018) Adriana V. F. Massicano et al. Molecular Imaging
- Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
- (2018) Ruisi Fu et al. ChemMedChem
- MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management
- (2018) Miguel Ángel Morcillo et al. Contrast Media & Molecular Imaging
- 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
- (2018) Frederike Bensch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models
- (2018) Thomas A. Burley et al. JOURNAL OF NUCLEAR MEDICINE
- Non-invasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients
- (2018) Xiaoyi Guo et al. MOLECULAR PHARMACEUTICS
- Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
- (2018) Vidya Narayanaswami et al. Molecular Imaging
- Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin
- (2018) Hye-Yeong Kim et al. ACS Nano
- Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing
- (2018) Adam Čepa et al. APPLIED RADIATION AND ISOTOPES
- Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer
- (2018) Francesco De Rose et al. JOURNAL OF NUCLEAR MEDICINE
- PET imaging of intra-arterial 89Zr bevacizumab in mice with and without osmotic opening of the blood-brain barrier: distinct advantage of intra-arterial delivery
- (2018) Wojciech G. Lesniak et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
- (2018) Frederike Bensch et al. NATURE MEDICINE
- The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma
- (2018) Junhun Cho et al. PATHOLOGY RESEARCH AND PRACTICE
- Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
- (2018) A. N. Niemeijer et al. Nature Communications
- Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy
- (2018) Patrícia M. R. Pereira et al. Nature Communications
- EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
- (2018) Francisco Sanchez-Vega et al. Cancer Discovery
- PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models
- (2018) Tae Lee et al. Cells
- Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer
- (2017) Dawei Jiang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
- (2017) Christopher G. England et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89 Zr-Df-ALT-836
- (2017) Reinier Hernandez et al. JOURNAL OF CONTROLLED RELEASE
- First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
- (2017) Gary A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- 89 Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection
- (2017) Eric W. Price et al. JOURNAL OF NUCLEAR MEDICINE
- 89 Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
- (2017) Suzanne C. van Es et al. JOURNAL OF NUCLEAR MEDICINE
- Multiregional Tumor Drug-Uptake Imaging by PET and Microvascular Morphology in End-Stage Diffuse Intrinsic Pontine Glioma
- (2017) Sophie E.M. Veldhuijzen van Zanten et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacokinetics, Biodistribution, and Radiation Dosimetry for89Zr-Trastuzumab in Patients with Esophagogastric Cancer
- (2017) Joseph A. O'Donoghue et al. JOURNAL OF NUCLEAR MEDICINE
- Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of 89 Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging
- (2017) Frank J. Warnders et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment
- (2017) Martin Pool et al. mAbs
- Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging
- (2017) Kelly D. Orcutt et al. MOLECULAR IMAGING AND BIOLOGY
- ImmunoPET Imaging of αvβ6 Expression Using an Engineered Anti-αvβ6 Cys-diabody Site-Specifically Radiolabeled with Cu-64: Considerations for Optimal Imaging with Antibody Fragments
- (2017) Jason B. White et al. MOLECULAR IMAGING AND BIOLOGY
- Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model
- (2017) Arutselvan Natarajan et al. MOLECULAR IMAGING AND BIOLOGY
- ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment
- (2017) Haiming Luo et al. MOLECULAR PHARMACEUTICS
- CD38 as a PET Imaging Target in Lung Cancer
- (2017) Emily B. Ehlerding et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer
- (2017) Christopher G. England et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer
- (2017) Emily B. Ehlerding et al. MOLECULAR PHARMACEUTICS
- Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with 89Zr-5B1
- (2017) Jacob L. Houghton et al. MOLECULAR PHARMACEUTICS
- 64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents
- (2017) Luke Yongkyu Kwon et al. MOLECULAR PHARMACEUTICS
- PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
- (2017) Judith van Loon et al. RADIOTHERAPY AND ONCOLOGY
- Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
- (2017) In Ho Song et al. Oncotarget
- Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
- (2017) Anna-Karin Haylock et al. Oncotarget
- PD-1/PD-L1 Pathway in Breast Cancer
- (2017) Florian Schütz et al. Oncology Research and Treatment
- Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma
- (2017) Masahiro Kikuchi et al. OncoImmunology
- Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients
- (2017) Gilmar Ferreira do Espírito Santo et al. World Journal of Gastrointestinal Oncology
- New Dioxaborolane Chemistry Enables [18F]-Positron-Emitting, Fluorescent [18F]-Multimodality Biomolecule Generation from the Solid Phase
- (2016) Erik A. Rodriguez et al. BIOCONJUGATE CHEMISTRY
- Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3
- (2016) C. D'Alessandria et al. CANCER RESEARCH
- Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer
- (2016) H. Luo et al. CLINICAL CANCER RESEARCH
- ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer
- (2016) Haiyan Sun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting the Human Epidermal Growth Factor Receptors with Immuno-PET: Imaging Biomarkers from Bench to Bedside
- (2016) G. Kramer-Marek et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging of Biomarkers in Breast Cancer
- (2016) G. A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis
- (2016) S. K. Sharma et al. JOURNAL OF NUCLEAR MEDICINE
- Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
- (2016) C. Bodet-Milin et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
- (2016) B. Behnam Azad et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging of Ovarian Cancer
- (2016) S. K. Sharma et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
- (2016) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Drug Imaging:89Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma
- (2016) Marc H. Jansen et al. JOURNAL OF NUCLEAR MEDICINE
- Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients
- (2016) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Pharmacokinetics and Biodistribution Studies of 89 Zr-Labeled Pembrolizumab
- (2016) Christopher G. England et al. JOURNAL OF NUCLEAR MEDICINE
- Development and preclinical studies of 64Cu-NOTA-pertuzumab F(ab′)2 for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT
- (2016) Karen Lam et al. mAbs
- Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
- (2016) M. H. A. Jansen et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Efficacy of an Antibody–Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89 Zr-ImmunoPET
- (2016) Anton G.T. Terwisscha van Scheltinga et al. MOLECULAR CANCER THERAPEUTICS
- LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence
- (2016) Xing Gong et al. MOLECULAR CANCER THERAPEUTICS
- [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
- (2016) Richard Laforest et al. MOLECULAR IMAGING AND BIOLOGY
- ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors
- (2016) Reinier Hernandez et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer
- (2016) Christopher G. England et al. MOLECULAR PHARMACEUTICS
- Focused Ultrasound Enhances Central Nervous System Delivery of Bevacizumab for Malignant Glioma Treatment
- (2016) Hao-Li Liu et al. RADIOLOGY
- Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
- (2016) D. L. J. Thorek et al. Science Translational Medicine
- Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis
- (2016) Wei-Wei Tang et al. OncoTargets and Therapy
- Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
- (2016) Aniek J.G. Even et al. Oncotarget
- Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab
- (2016) Martin Pool et al. Oncotarget
- CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody
- (2016) Reinier Hernandez et al. Theranostics
- Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
- (2016) Jens Sörensen et al. Theranostics
- Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
- (2016) Yvonne W. S. Jauw et al. Frontiers in Pharmacology
- Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
- (2016) Edward K. Fung et al. EJNMMI Research
- l-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
- (2016) Fook T. Lee et al. Molecular Imaging
- Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas
- (2016) A. G. de Lucas et al. PLoS One
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Novel Radiotracer for ImmunoPET Imaging of PD-1 Checkpoint Expression on Tumor Infiltrating Lymphocytes
- (2015) Arutselvan Natarajan et al. BIOCONJUGATE CHEMISTRY
- Abstract 2859: Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer (TNBC)
- (2015) Leisha A. Emens et al. CANCER RESEARCH
- An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
- (2015) R. Tavare et al. CANCER RESEARCH
- ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
- (2015) L. E. Lamberts et al. CLINICAL CANCER RESEARCH
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- (2015) N. Pandit-Taskar et al. CLINICAL CANCER RESEARCH
- PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging
- (2015) L. K. van Dijk et al. CLINICAL CANCER RESEARCH
- PET of EGFR with64Cu-cetuximab-F(ab′)2in mice with head and neck squamous cell carcinoma xenografts
- (2015) Laura K. van Dijk et al. Contrast Media & Molecular Imaging
- Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
- (2015) Marc Peeters et al. DRUGS
- Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
- (2015) Diana Spiegelberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
- (2015) ANNA-KARIN HAYLOCK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging
- (2015) Melissa N. McCracken et al. JOURNAL OF CLINICAL INVESTIGATION
- Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses
- (2015) J. L. Houghton et al. JOURNAL OF NUCLEAR MEDICINE
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- (2015) M. Keyaerts et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Labeled Versus 124I-Labeled HER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo
- (2015) C. T. Mendler et al. JOURNAL OF NUCLEAR MEDICINE
- TGF- Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
- (2015) M. W. den Hollander et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer
- (2015) P. Heidari et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab
- (2015) H. Luo et al. JOURNAL OF NUCLEAR MEDICINE
- Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159
- (2015) H. Wang et al. JOURNAL OF NUCLEAR MEDICINE
- Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model
- (2015) Zéna Wimana et al. MOLECULAR IMAGING AND BIOLOGY
- Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors
- (2015) A. Craig Lockhart et al. MOLECULAR IMAGING AND BIOLOGY
- PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using 64Cu-Labeled Monoclonal Antibody 61B
- (2015) Bin Zhou et al. MOLECULAR PHARMACEUTICS
- Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics
- (2015) Brian M. Zeglis et al. MOLECULAR PHARMACEUTICS
- Tumor and organ uptake of 64Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies
- (2015) Jae-Ho Lee et al. NUCLEAR MEDICINE AND BIOLOGY
- Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with 99m Tc-peptide-Z HER2:342
- (2015) Jingmian Zhang et al. NUCLEAR MEDICINE AND BIOLOGY
- MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using 64Cu-NOTA-panitumumab F(ab')2 fragments
- (2015) Amanda J. Boyle et al. NUCLEAR MEDICINE AND BIOLOGY
- Preclinical evaluation of 89Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model
- (2015) Aya Sugyo et al. NUCLEAR MEDICINE COMMUNICATIONS
- Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role
- (2015) Qinghua Yuan et al. PLoS One
- Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry
- (2015) Haiming Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CD146 with a64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas
- (2015) Yunan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer
- (2015) Jacob L. Houghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk
- (2015) Sho-ichi Yamagishi et al. REJUVENATION RESEARCH
- 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
- (2015) Catherina Willemien Menke-van der Houven et al. Oncotarget
- Evaluation of 68Ga-Labeled MG7 Antibody: A Targeted Probe for PET/CT Imaging of Gastric Cancer
- (2015) Bing Xu et al. Scientific Reports
- Affibody-mediated PET imaging of HER3 expression in malignant tumours
- (2015) Maria Rosestedt et al. Scientific Reports
- EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study
- (2015) Simon Puttick et al. Molecular Imaging
- PET/CT With 124I-cG250: Great Potential and Some Open Questions
- (2014) Amir H. Khandani et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with 44Sc-Labeled Cetuximab Fab Fragment
- (2014) Rubel Chakravarty et al. BIOCONJUGATE CHEMISTRY
- Imaging of hepatocellular carcinoma patient-derived xenografts using 89Zr-labeled anti-glypican-3 monoclonal antibody
- (2014) Xiaoyang Yang et al. BIOMATERIALS
- Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
- (2014) Natsuko Nomura et al. Cancer Cell International
- Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of Prostate Cancer
- (2014) S. M. Knowles et al. CLINICAL CANCER RESEARCH
- 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
- (2014) S. B. M. Gaykema et al. CLINICAL CANCER RESEARCH
- Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma
- (2014) Sarah M. Cheal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer
- (2014) A. G. T. Terwisscha van Scheltinga et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
- (2014) S. F. Oosting et al. JOURNAL OF NUCLEAR MEDICINE
- Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
- (2014) S. J. van Asselt et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
- (2014) S. M. Knowles et al. JOURNAL OF NUCLEAR MEDICINE
- Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- Anti-MET ImmunoPET for Non-Small Cell Lung Cancer Using Novel Fully Human Antibody Fragments
- (2014) K. Li et al. MOLECULAR CANCER THERAPEUTICS
- Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-2 x Anti-HSG Bispecific Antibody in Mice with PC3 Xenografts
- (2014) Catharina M. van Rij et al. MOLECULAR IMAGING AND BIOLOGY
- Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
- (2014) Nerissa Therese Viola-Villegas et al. MOLECULAR PHARMACEUTICS
- Generation and Screening of Monoclonal Antibodies for ImmunoPET Imaging of IGF1R in Prostate Cancer
- (2014) Hao Hong et al. MOLECULAR PHARMACEUTICS
- Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo
- (2014) Joanna Strand et al. MOLECULAR PHARMACEUTICS
- Design, Synthesis, and Validation of Axl-Targeted Monoclonal Antibody Probe for microPET Imaging in Human Lung Cancer Xenograft
- (2014) Shuanglong Liu et al. MOLECULAR PHARMACEUTICS
- Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
- (2014) Bernadette V. Marquez et al. MOLECULAR PHARMACEUTICS
- Noninvasive positron emission tomography and fluorescence imaging of CD133+tumor stem cells
- (2014) Simone Gaedicke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer
- (2014) Idris Bahce et al. EJNMMI Research
- In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
- (2014) Anna-Karin Haylock et al. EJNMMI Research
- Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging
- (2014) Sai Kiran Sharma et al. EJNMMI Research
- Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
- (2014) Raju R Raval et al. Journal for ImmunoTherapy of Cancer
- The Role of Mesothelin in Tumor Progression and Targeted Therapy
- (2013) Zhewei Tang et al. Anti-Cancer Agents in Medicinal Chemistry
- ImmunoPET Imaging of Renal Cell Carcinoma with 124I- and 89Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
- (2013) Alexander B. Stillebroer et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake
- (2013) M. Arjaans et al. CANCER RESEARCH
- PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
- (2013) Ronnie C. Mease et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- PET imaging of CD105/endoglin expression with a 61/64Cu-labeled Fab antibody fragment
- (2013) Yin Zhang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody
- (2013) Catharina M. van Rij et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Preparation of clinical-grade89Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy
- (2013) Ling Wei et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
- (2013) S. B. M. Gaykema et al. JOURNAL OF NUCLEAR MEDICINE
- Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
- (2013) Y. Y. Janjigian et al. JOURNAL OF NUCLEAR MEDICINE
- Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment
- (2013) M. Glaser et al. JOURNAL OF NUCLEAR MEDICINE
- Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology
- (2013) N. T. Viola-Villegas et al. JOURNAL OF NUCLEAR MEDICINE
- A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry
- (2013) B. M. Zeglis et al. JOURNAL OF NUCLEAR MEDICINE
- 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
- (2013) K. Tamura et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET
- (2013) J. E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical evaluation of89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys
- (2013) Danielle J Vugts et al. mAbs
- Engineered antibodies for molecular imaging of cancer
- (2013) Anna M. Wu METHODS
- Pilot study of 68Ga-DOTA-F(ab′)2-trastuzumab in patients with breast cancer
- (2013) Volkan Beylergil et al. NUCLEAR MEDICINE COMMUNICATIONS
- Detection of Rapalog-Mediated Therapeutic Response in Renal Cancer Xenografts Using 64Cu-bevacizumab ImmunoPET
- (2013) Albert J. Chang et al. PLoS One
- Evaluation of 89Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
- (2013) Aya Sugyo et al. PLoS One
- Cell-Autonomous and Non-Cell-Autonomous Mechanisms of HGF/MET-Driven Resistance to Targeted Therapies: From Basic Research to a Clinical Perspective
- (2013) S. Corso et al. Cancer Discovery
- Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model
- (2012) A. R. M. van der Bilt et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
- (2012) Farhad Azimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial
- (2012) Chaitanya R. Divgi et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular targeting of CEACAM6 using antibody probes of different sizes
- (2012) Gang Niu et al. JOURNAL OF CONTROLLED RELEASE
- Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab
- (2012) E. M. Jagoda et al. JOURNAL OF NUCLEAR MEDICINE
- Immuno-PET of Tissue Factor in Pancreatic Cancer
- (2012) H. Hong et al. JOURNAL OF NUCLEAR MEDICINE
- PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted 89Zr-Labeled Panitumumab
- (2012) T. K. Nayak et al. JOURNAL OF NUCLEAR MEDICINE
- Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and a Monoclonal Antibody Dual-Labeled with 89Zr and IRDye 800CW
- (2012) Hao Hong et al. MOLECULAR PHARMACEUTICS
- A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
- (2012) Michelle L. James et al. PHYSIOLOGICAL REVIEWS
- Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection
- (2012) Bin-Bin Su WORLD JOURNAL OF GASTROENTEROLOGY
- Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen
- (2012) David Ulmert et al. Cancer Discovery
- Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method
- (2012) Rafke Schoffelen et al. EJNMMI Research
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity
- (2011) R. Sawada et al. CLINICAL CANCER RESEARCH
- Positron emission tomography imaging of CD105 expression during tumor angiogenesis
- (2011) Hao Hong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105
- (2011) Hao Hong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
- (2011) J. A. O'Donoghue et al. JOURNAL OF NUCLEAR MEDICINE
- Correlation of In Vivo and In Vitro Measures of Carbonic Anhydrase IX Antigen Expression in Renal Masses Using Antibody 124I-cG250
- (2011) D. A. Pryma et al. JOURNAL OF NUCLEAR MEDICINE
- 124I-huA33 Antibody PET of Colorectal Cancer
- (2011) J. A. Carrasquillo et al. JOURNAL OF NUCLEAR MEDICINE
- HER1-Targeted 86Y-Panitumumab Possesses Superior Targeting Characteristics than 86Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
- (2011) Tapan K. Nayak et al. PLoS One
- Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
- (2011) Mark D Girgis et al. EJNMMI Research
- Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
- (2011) Caroline Rousseau et al. EJNMMI Research
- In vitro and in vivo pre-clinical analysis of a F(ab')2 fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
- (2011) Karen J Wong et al. EJNMMI Research
- VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
- (2010) W. B. Nagengast et al. CANCER RESEARCH
- Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with 64Cu-labeled trastuzumab PET
- (2010) Pramila Paudyal et al. CANCER SCIENCE
- Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts
- (2010) Bishnuhari Paudyal et al. CANCER SCIENCE
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
- (2010) Eric J. Lepin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging of tumor angiogenesis in mice with VEGF-A-targeted 86Y-CHX-A″-DTPA-bevacizumab
- (2010) Tapan K. Nayak et al. INTERNATIONAL JOURNAL OF CANCER
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
- (2010) W. B. Nagengast et al. JOURNAL OF NUCLEAR MEDICINE
- Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a68Ga- and18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
- (2010) Rafke Schoffelen et al. MOLECULAR CANCER THERAPEUTICS
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA
- (2010) Karen Alt et al. PROSTATE
- Antibody Vectors for Imaging
- (2010) Tove Olafsen et al. SEMINARS IN NUCLEAR MEDICINE
- Immuno-Positron Emission Tomography in Cancer Models
- (2010) Smitha Reddy et al. SEMINARS IN NUCLEAR MEDICINE
- Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
- (2009) Nina E. Weisser et al. BIOTECHNOLOGY ADVANCES
- 89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft
- (2009) Thijs H. Oude Munnink et al. EUROPEAN JOURNAL OF CANCER
- Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab
- (2009) Gang Niu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen
- (2009) U. Elsasser-Beile et al. JOURNAL OF NUCLEAR MEDICINE
- PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
- (2009) G. Niu et al. JOURNAL OF NUCLEAR MEDICINE
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
- (2009) Yaojiong Wu et al. STEM CELLS AND DEVELOPMENT
- Quantitative Serial Imaging of an 124I Anti-CEA Monoclonal Antibody in Tumor-Bearing Mice
- (2008) James R. Bading et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using 111In-J591: Lesion Detectability and Dosimetric Projections for 90Y Radioimmunotherapy
- (2008) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
- (2008) H. J.W.L. Aerts et al. JOURNAL OF NUCLEAR MEDICINE
- Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3
- (2008) Armando Bartolazzi et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search